Amyloid β peptides appear to play a role in physiological processes; however, they are also involved in the pathogenesis of Alzheimer disease. Their actions under normal conditions are probably mediated by soluble monomeric L-isoforms at low concentrations, perhaps via highly specific interactions. On the contrary, toxic effects of aggregated natural L-isoforms/synthetic D-isoforms on membranes are very similar, but synthetic reverse/random L: -isoforms without pronounced aggregation properties are not toxic. Our previous work reported interactions of non-aggregated/aggregated L-isoforms of amyloid β peptides 1-40/1-42 with racemic 24-hydroxycholesterol. In this study, stereospecificity in the interactions of natural 24(S)hydroxycholesterol (cerebrosterol) or synthetic 24(R)hydroxycholesterol with soluble fragment 1-40 was evaluated by means of an in vitro test based on increased vulnerability of the hemicholinium-3 sensitive high-affinity choline uptake system in rat hippocampal cholesterol-depleted synaptosomes to the actions of amyloid β; computational simulations were also performed. Our results suggest that: (1) 24(S)hydroxycholesterol interacts with L-peptide 1-40 but not with the reverse L-peptide 40-1, (2) 24(R)hydroxycholesterol does not interact with L-peptide 1-40 or reverse 40-1, and (3) both enantiomers can probably interact with D-peptide 1-40. Therefore, the binding of 24(S)hydroxycholesterol is not fully stereospecific and the interaction could not reflect a physiological mechanism. Data from the computational simulation indicate that the hydrophobic core of the amyloid β molecule interacts with the hydrophobic part of 24(S)hydroxycholesterol, but no hydrogen bonds with high stability were found. Using this procedure, globular amyloid β could retain 24(S)hydroxycholesterol and thus contribute to its pathological accumulation in the brains of patients with Alzheimer disease.

Alzheimer Disease Centre Prague Psychiatric Centre Ústavní 91 181 03 Prague 8 Bohnice Czech Republic

Zobrazit více v PubMed

J Lipid Res. 2000 May;41(5):840-5 PubMed

Anal Biochem. 1976 May 7;72:248-54 PubMed

Biochemistry. 2005 Jan 11;44(1):157-64 PubMed

J Biol Chem. 1997 May 9;272(19):12601-5 PubMed

Mol Psychiatry. 2002;7(8):899-902 PubMed

Chembiochem. 2006 Feb;7(2):257-67 PubMed

Biopolymers. 1999 May;49(6):505-14 PubMed

J Neurochem. 1998 May;70(5):2179-87 PubMed

Nature. 1997 Oct 16;389(6652):689-95 PubMed

Biophys J. 1995 Aug;69(2):640-51 PubMed

J Mol Biol. 2004 Nov 26;344(3):757-67 PubMed

J Physiol. 2006 Aug 15;575(Pt 1):5-10 PubMed

Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10417-22 PubMed

J Biol Chem. 1997 Mar 14;272(11):7431-6 PubMed

Ann N Y Acad Sci. 1997 Apr 24;814:1-16 PubMed

RNA. 2009 Jun;15(6):1219-30 PubMed

Eur Psychiatry. 2009 Apr;24(3):183-90 PubMed

Proteins. 2004 May 1;55(2):383-94 PubMed

Neurosci Lett. 1997 Sep 26;234(1):71-3 PubMed

J Neurochem. 2002 Dec;83(5):1110-9 PubMed

Trends Neurosci. 2004 Jan;27(1):1-3 PubMed

J Biol Chem. 1996 Jul 26;271(30):18032-44 PubMed

J Mol Neurosci. 2008;34(1):35-43 PubMed

Trends Neurosci. 1998 Jan;21(1):43-9 PubMed

Acta Neurobiol Exp (Wars). 2004;64(1):71-9 PubMed

Neurochem Res. 2008 Mar;33(3):412-21 PubMed

Biochemistry. 2001 Jul 24;40(29):8563-71 PubMed

Neurobiol Aging. 2011 Feb;32(2):235-48 PubMed

J Pept Sci. 2004 May;10(5):229-48 PubMed

Arch Gerontol Geriatr. 1993 Nov-Dec;17(3):179-88 PubMed

Biochem Biophys Res Commun. 2007 Jul 20;359(1):46-50 PubMed

J Biol Chem. 2004 Aug 13;279(33):34674-81 PubMed

Lipids. 2007 Feb;42(1):5-14 PubMed

Eur J Neurosci. 2010 Mar;31(5):788-96 PubMed

J Chem Theory Comput. 2007 Nov;3(6):2312-34 PubMed

Neurochem Res. 2001 Mar;26(3):203-12 PubMed

Biophys J. 2000 Aug;79(2):934-44 PubMed

Sex-Dependent Changes in Striatal Dopamine Transport in Preadolescent Rats Exposed Prenatally and/or Postnatally to Methamphetamine

Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions